Literature DB >> 29322815

Bioinformatic analysis of PFN2 dysregulation and its prognostic value in head and neck squamous carcinoma.

Jiyuan Liu1, Yunlong Wu1, Qizhang Wang1, Xian Liu1, Xuejuan Liao1, Jian Pan1.   

Abstract

AIM: This study aimed to identify PFN2 expression profile, its prognostic value and the mechanism of its dysregulation in head and neck squamous cell carcinoma (HNSC). MATERIALS &
METHODS: Bioinformatic analysis was performed using data in the Gene Expression Omnibus Datasets, Human Protein Atlas and The Cancer Genome Atlas-HNSC.
RESULTS: PFN2 was upregulated in HNSC than in normal head and neck tissues. High PFN2 expression independently predicted poor overall survival in primary HNSC (hazard ratio: 1.548, 95% CI: 1.174-2.042; p = 0.002). Fourteen percent of HNSC cases had PFN2 amplification. PFN2 DNA methylation was negatively correlated with its mRNA expression (Pearson's r = -0.713).
CONCLUSION: High PFN2 expression might serve as a valuable predictor for poor overall survival of HNSC. DNA amplification and hypomethylation might be two mechanisms of PFN2 dysregulation.

Entities:  

Keywords:  HNSC; PFN2; amplification; methylation; survival

Mesh:

Substances:

Year:  2018        PMID: 29322815     DOI: 10.2217/fon-2017-0348

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  6 in total

1.  Circ_0008500 Knockdown Improves Radiosensitivity and Inhibits Tumorigenesis in Breast Cancer Through the miR-758-3p/PFN2 Axis.

Authors:  Deyou Kong; Dongxing Shen; Zhikun Liu; Jun Zhang; Jian Zhang; Cuizhi Geng
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-03-03       Impact factor: 2.673

2.  Overexpression of TRMT12 may independently predict poor overall survival in patients with head and neck squamous cell carcinoma.

Authors:  Kai Wang; Mengmeng Zheng; Yuan Ren
Journal:  Onco Targets Ther       Date:  2019-09-05       Impact factor: 4.147

3.  Machine learning with the TCGA-HNSC dataset: improving usability by addressing inconsistency, sparsity, and high-dimensionality.

Authors:  Michael C Rendleman; John M Buatti; Terry A Braun; Brian J Smith; Chibuzo Nwakama; Reinhard R Beichel; Bart Brown; Thomas L Casavant
Journal:  BMC Bioinformatics       Date:  2019-06-17       Impact factor: 3.169

4.  Profilin 2 promotes growth, metastasis, and angiogenesis of small cell lung cancer through cancer-derived exosomes.

Authors:  Qi Cao; Yihan Liu; Ying Wu; Caijiao Hu; Lei Sun; Jinghui Wang; Changlong Li; Meng Guo; Xin Liu; Jianyi Lv; Xueyun Huo; Junming Yue; Xiaoyan Du; Zhenwen Chen
Journal:  Aging (Albany NY)       Date:  2020-11-21       Impact factor: 5.682

5.  Profilin 2 Promotes Proliferation and Metastasis of Head and Neck Cancer Cells by Regulating PI3K/AKT/β-Catenin Signaling Pathway.

Authors:  Kecheng Zhou; Jie Chen; Jiayu Wu; Yangxinzi Xu; Qiaoyun Wu; Jingjing Yue; Yu Song; Shengcun Li; Peng Zhou; Wenzhan Tu; Guanhu Yang; Songhe Jiang
Journal:  Oncol Res       Date:  2019-05-15       Impact factor: 5.574

6.  Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.

Authors:  Hui Zhang; Weiqiang Yang; Jinlong Yan; Kaiping Zhou; Boshun Wan; Peidong Shi; Yueyu Chen; Songbing He; Dechun Li
Journal:  Int J Oncol       Date:  2018-07-09       Impact factor: 5.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.